Gencan Capital Inc

PINK:GNCNF USA Shell Companies
Market Cap
$179.07K
Market Cap Rank
#39819 Global
#12951 in USA
Share Price
$0.01
Change (1 day)
+0.00%
52-Week Range
$0.01 - $0.02
All Time High
$1.49
About

Gencan Capital Inc. does not have significant operations. Previously, the company was involved in the solar energy generation activity. The company was formerly known as Genterra Energy Inc. and changed its name to Gencan Capital Inc. in August 2015. Gencan Capital Inc. was incorporated in 2013 and is based in Toronto, Canada.

Gencan Capital Inc (GNCNF) - Net Assets

Latest net assets as of September 2025: $-23.26K USD

Based on the latest financial reports, Gencan Capital Inc (GNCNF) has net assets worth $-23.26K USD as of September 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($11.39K) and total liabilities ($34.65K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets $-23.26K
% of Total Assets -204.13%
Annual Growth Rate N/A
5-Year Change -106.19%
10-Year Change -127.36%
Growth Volatility 191.8

Gencan Capital Inc - Net Assets Trend (2004–2025)

This chart illustrates how Gencan Capital Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Gencan Capital Inc (2004–2025)

The table below shows the annual net assets of Gencan Capital Inc from 2004 to 2025.

Year Net Assets Change
2025-09-30 $-23.26K -173.59%
2024-09-30 $31.60K -52.12%
2023-09-30 $66.01K -53.48%
2022-09-30 $141.90K -62.22%
2021-09-30 $375.62K -24.52%
2020-09-30 $497.66K -14.24%
2019-09-30 $580.30K -15.37%
2018-09-30 $685.71K +803.36%
2017-09-30 $75.91K -10.71%
2016-09-30 $85.01K +58.72%
2015-09-30 $53.56K +294.33%
2014-09-30 $-27.56K -100.09%
2013-09-30 $31.92 Million -0.66%
2012-09-30 $32.13 Million -2.46%
2011-09-30 $32.94 Million +105.19%
2009-09-30 $16.05 Million +0.72%
2008-09-30 $15.94 Million -5.08%
2007-09-30 $16.79 Million +5.57%
2006-09-30 $15.90 Million +5.89%
2005-09-30 $15.02 Million +10.23%
2004-09-30 $13.63 Million --

Equity Component Analysis

This analysis shows how different components contribute to Gencan Capital Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 112.9% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (September 2025)

Component Amount Percentage
Other Components $81.22K %
Total Equity $-23.26K 100.00%

Gencan Capital Inc Competitors by Market Cap

The table below lists competitors of Gencan Capital Inc ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Gencan Capital Inc's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 31,601 to -23,256, a change of -54,857 (-173.6%).
  • Net loss of 54,934 reduced equity.
  • Other factors increased equity by 77.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income $-54.93K -236.21%
Other Changes $77.00 +0.33%
Total Change $- -173.59%

Book Value vs Market Value Analysis

This analysis compares Gencan Capital Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2018-09-30 $0.04 $0.01 x
2019-09-30 $0.04 $0.01 x
2020-09-30 $0.03 $0.01 x
2021-09-30 $0.02 $0.01 x
2022-09-30 $0.01 $0.01 x
2023-09-30 $0.00 $0.01 x
2024-09-30 $0.00 $0.01 x
2025-09-30 $0.00 $0.01 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Gencan Capital Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 0.00%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 0.00%
  • • Asset Turnover: 0.00x
  • • Equity Multiplier: 0.00x
  • Recent ROE (0.00%) is above the historical average (-20.21%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2004 5.79% 34.69% 0.11x 1.50x $-573.06K
2005 7.16% 34.07% 0.15x 1.44x $-426.98K
2006 5.57% 24.83% 0.16x 1.42x $-705.38K
2007 5.24% 28.68% 0.14x 1.33x $-799.57K
2008 1.90% 10.88% 0.10x 1.71x $-1.29 Million
2009 0.72% 3.54% 0.12x 1.73x $-1.49 Million
2011 -0.87% -8.74% 0.07x 1.37x $-3.58 Million
2012 -1.69% -15.30% 0.08x 1.46x $-3.76 Million
2013 -0.67% -6.77% 0.06x 1.53x $-3.40 Million
2014 0.00% 3.82% 1.46x 0.00x $146.40K
2015 151.46% 16.35% 0.18x 50.90x $75.76K
2016 37.00% 5.78% 0.20x 32.43x $22.95K
2017 -11.99% -1.92% 0.21x 29.59x $-16.69K
2018 88.93% 183.03% 0.37x 1.31x $541.23K
2019 -18.09% 0.00% 0.00x 1.03x $-163.03K
2020 -16.61% 0.00% 0.00x 1.04x $-132.41K
2021 -32.49% 0.00% 0.00x 1.15x $-159.61K
2022 -164.91% 0.00% 0.00x 1.40x $-248.19K
2023 -114.98% 0.00% 0.00x 1.58x $-82.49K
2024 -365.84% 0.00% 0.00x 1.64x $-118.77K
2025 0.00% 0.00% 0.00x 0.00x $-52.61K

Industry Comparison

This section compares Gencan Capital Inc's net assets metrics with peer companies in the Shell Companies industry.

Industry Context

  • Industry: Shell Companies
  • Average net assets among peers: $36,677,338
  • Average return on equity (ROE) among peers: -64.57%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Gencan Capital Inc (GNCNF) $-23.26K 5.79% N/A $170.28K
Artius II Acquisition Inc. Class A Ordinary Shares (AACB) $-60.27K 0.00% 0.00x $198.37 Million
Artius II Acquisition Inc. Units (AACBU) $-60.27K 0.00% 0.00x $205.28 Million
Ares Acquisition Corporation II (AACT-UN) $931.34 Million 0.00% 0.08x $399.77 Million
AA Mission Acquisition Corp. (AAM-UN) $-559.90 Million 0.00% 0.00x $349.76 Million
Global Acquisitions Corporation (AASP) $3.80 Million -5.26% 0.34x $15.42 Million
ABV Consulting Inc (ABVN) $8.75K -623.31% 2.50x $461.96K
Atlantic Coastal Acquisition Corp II (ACAB) $-8.52 Million 0.00% 0.00x $2.44 Million
Annabidiol Corp (ACBD) $-501.57K 0.00% 0.00x $13.62K
ACRO Biomedical Co Ltd (ACBM) $685.87K -17.12% 0.46x $30.04K
Huaizhong Health Group Inc (ADAD) $-19.47K 0.00% 0.00x $3.15K